Theravance Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
George Town, Grand Cayman, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Theravance Biopharma, Inc. has filed 1,125 SEC EDGAR filings since 01 Aug 2013

SEC filing history

Showing 501-525 of 1,000 matching filings.

Per page
25
Current page
21
4

FORM 4 -

Filing date
24 Aug 2020
Reporting date
20 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
10 Aug 2020
Reporting date
03 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
29 Jul 2020
Reporting date
27 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SC 13G/A filing

Filing date
10 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
06 Jul 2020
Reporting date
01 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
06 Jul 2020
Reporting date
01 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SC 13G/A

Filing date
23 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Jun 2020
Reporting date
22 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88552

AMENDED SC13D

Filing date
22 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88552

SC 13D/A

Filing date
17 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88552

THERAVANCE BIOPHARMA, INC.

Filing date
11 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .